61st EASD Annual Meeting of the European Association for the Study of Diabetes Diabetologia Springer Nature Link In Chinese adults with overweight or obesity, once weekly #GLP glucagon agonist mazdutide, at a dose of 4 mg or 6 mg for 32 48 weeks, led to clinically relevant #weightloss in the Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors Nature Communications Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet